ArticleJTO clinical and research reports2022

The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC.

Hiroaki Kanemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.